Related Experiment Videos
Haemophilus influenzae type b vaccine: use in the pediatric population
V J Gururaj1, J K Patrick, P F Rogers
1Department of Pediatrics, Texas Tech University Health Sciences Center, School of Medicine, Lubbock 79430.
Insights
Many children lack access to the Haemophilus influenzae type b (Hib) vaccine due to cost and availability issues, particularly those served by community and health department clinics. Strategies to improve Hib vaccine uptake are crucial for pediatric public health.
Area of Science:
- Pediatrics
- Vaccinology
- Public Health
Background:
- The Haemophilus influenzae type b (Hib) vaccine is critical for preventing serious childhood infections.
- Disparities in vaccine access may exist among different healthcare settings.
Purpose of the Study:
- To evaluate the utilization of the Hib vaccine in pediatric populations.
- To understand healthcare professionals' attitudes towards Hib vaccine administration.
- To identify barriers to Hib vaccine use in Texas.
Main Methods:
- A study was conducted across various clinic types in Texas: community clinics, health department clinics, university-based teaching clinics, and private practice groups.
- Data collection focused on vaccine administration rates, vaccine availability, and reasons for non-use.
Main Results:
- Private and university clinics showed high Hib vaccine administration and availability (over 57% and 95% respectively).
- Community and health department clinics reported very low administration rates (never administered by over 72% and 81% respectively) and availability (below 23% and 16% respectively).
- Key barriers identified were vaccine non-availability and high cost.
Conclusions:
- Significant access gaps for the Hib vaccine exist, disproportionately affecting children relying on community and health department clinics.
- Recommendations include free vaccine provision, enhanced patient education on benefits, and mandatory administration laws for daycare entry to improve Hib vaccine coverage.
Abstract:
To assess the use of the Haemophilus influenzae type b vaccine and the attitudes of health professionals regarding its use in the pediatric population, we conducted a study of community clinics, health department clinics, university-based teaching clinics, and private practice groups in the state of Texas. Whereas 59.6% of the private practice groups and 57.1% of the university-based teaching clinics administered the vaccine to more than 75% of their eligible children, 72.7% of community clinics and 81.7% of health department clinics never administered the vaccine to their eligible children. Likewise, whereas 100% of the university-based teaching clinics and 95.7% of the private practice groups had the vaccine available to their patients, only 22.7% of the community clinics and 15.5% of the health department clinics did so. The two most common reasons given by health professionals concerning the nonuse of the vaccine were nonavailability and high cost of the vaccine. Our findings suggest that a large segment of eligible children do not have access to this important vaccine and that children who depend on community and health department clinics for their routine health care are particularly affected in this regard. Strategies identified to increase the use of the vaccine include providing vaccine free of charge, increasing patient awareness of the vaccine benefits, and passing mandatory state laws requiring vaccine administration before day-care enrollment.